CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y, Ishida T, Masaki A, Murase T, Ohtsuka E, Takeshita M, Muto R, Iwasaki H, Ito A, Kusumoto S, Nakano N, Tokunaga M, Yonekura K, Tashiro Y, Iida S, Utsunomiya A, Ueda R, Inagaki H.
Sakamoto Y, et al. Among authors: utsunomiya a.
Hematol Oncol. 2022 Dec;40(5):876-884. doi: 10.1002/hon.3072. Epub 2022 Sep 6.
Hematol Oncol. 2022.
PMID: 36043457
Free PMC article.